Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
Riitta Lassila, Professor of Coagulation Medicine at University of Helsinki, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Our team has published about how the heparin proteoglycan mimic APAC impacts the interplay between complement system and coagulation.
The regulatory functions and cellular clearance of debris are supported – an anti-inflammatory effect aligning with the antithrombotic mechanisms of APAC (by Aplagon).”
Title: Interactions of Antiplatelet, Anticoagulant (APAC) with C1q and FH modulate complement activation on injured cells
Authors: Juha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, Riitta Lassila, Seppo Meri
Read the Full Article on Blood Vessels, Thrombosis and Hemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?